Teacher Retirement System of Texas’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,384
Closed -$239K 1615
2025
Q4
$239K Sell
6,384
-4,183
-40% -$138K ﹤0.01% 1483
2025
Q3
$291K Sell
10,567
-1,014
-9% -$34.9K ﹤0.01% 1757
2025
Q2
$366K Buy
11,581
+98
+0.9% +$3.15K ﹤0.01% 1696
2025
Q1
$381K Sell
11,483
-318
-3% -$11.4K ﹤0.01% 1635
2024
Q4
$406K Buy
11,801
+3,964
+51% +$136K ﹤0.01% 1317
2024
Q3
$313K Buy
7,837
+977
+14% +$34.3K ﹤0.01% 1330
2024
Q2
$207K Sell
6,860
-309
-4% -$9.29K ﹤0.01% 1475
2024
Q1
$241K Sell
7,169
-596
-8% -$19.1K ﹤0.01% 1536
2023
Q4
$251K Sell
7,765
-2,451
-24% -$68.4K ﹤0.01% 1610
2023
Q3
$335K Buy
10,216
+1,273
+14% +$44.2K ﹤0.01% 1543
2023
Q2
$315K Buy
8,943
+1,634
+22% +$56.4K ﹤0.01% 1606
2023
Q1
$239K Buy
+7,309
New +$333K ﹤0.01% 1817
2022
Q4
Sell
-17,256
Closed -$764K 2127
2022
Q3
$764K Buy
+17,256
New +$842K 0.01% 1307

Other funds holding HRMY

Teacher Retirement System of Texas's HRMY Position: Q1 2026 in Review

Teacher Retirement System of Texas sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 6,384 shares — an estimated $239K sold.

Teacher Retirement System of Texas first reported a position in HRMY in Q3 2022 and held it in 13 quarters. The position peaked at $764K in Q3 2022. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Teacher Retirement System of Texas reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • Teacher Retirement System of Texas sold 6,384 Harmony Biosciences shares in Q1 2026, an estimated $239K.
  • Teacher Retirement System of Texas first reported a position in Harmony Biosciences in Q3 2022 and held it in 13 quarters.
  • Teacher Retirement System of Texas's Harmony Biosciences position peaked at $764K in Q3 2022.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Teacher Retirement System of Texas's 13F filing for Q1 2026, filed 30 Apr 2026.